Highlights

  • Voluntary recall of three US batches due to detection of cereulide toxin
  • No reported illnesses; issue limited to a small quantity of products
  • No financial or global product impact expected

Overview

The a2 Milk Company (NZX:ATM) has initiated a voluntary recall of three batches of its a2 Platinum USA infant formula following the detection of cereulide, a toxin linked to food contamination. The affected product, manufactured by Synlait Milk Limited, was sold exclusively in the United States via online platforms and select retail channels. Importantly, the product had already been discontinued before the recall began. No cases of illness have been reported. The recall involves a limited Volume and is not expected to materially impact the company’s financial performance or its products sold outside the US.

What Triggered the Recall and Is It a Health Concern?

The recall was initiated after additional testing detected cereulide following updated guidance from New Zealand regulators. This toxin can cause short-term gastrointestinal symptoms such as nausea and vomiting, typically resolving within 24 hours. However, no adverse health incidents have been reported. The company has coordinated with the U.S. Food and Drug Administration and issued guidance to affected consumers as a precautionary measure.

Does This Recall Affect Products Outside the United States?

No, the recall is strictly limited to the US-labelled version of a2 Platinum infant formula. Products sold in regions such as Australia, New Zealand, South Korea, Vietnam, and China remain unaffected. The formulation and ingredient linked to the issue are specific to the US product. This ensures that the company’s global operations and consumer confidence in other markets remain intact.